FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 51 through 100 of 255

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
CLDI NYSE American Calidi Biotherapeutics, Inc. 2830
CLNN Nasdaq Clene Inc. 2830
CMND Nasdaq Clearmind Medicine Inc. 2830
CMPX Nasdaq Compass Therapeutics, Inc. 2830
CNTN Nasdaq Canton Strategic Holdings, Inc. 2830
CNTX Nasdaq Context Therapeutics Inc. 2830
COCP Nasdaq Cocrystal Pharma, Inc. 2830
COLL Nasdaq Collegium Pharmaceutical, Inc. 2830
CORT Nasdaq Corcept Therapeutics Incorporated 2830
CPIX Nasdaq Cumberland Pharmaceuticals Inc. 2830
CRDL Nasdaq Cardiol Therapeutics Inc. 2830
CRL New York Charles River Laboratories International 2830
CRON Nasdaq Cronos Group Inc. 2830
CRSP Nasdaq CRISPR Therapeutics AG 2830
CSWYY Over the counter China Shineway Pharmaceutical Group Limi 2830
CTNM Nasdaq Contineum Therapeutics, Inc. 2830
CTXR Nasdaq Citius Pharmaceuticals, Inc. 2830
CUPR Nasdaq Cuprina Holdings (Cayman) Limited 2830
CURX Nasdaq Curanex Pharmaceuticals Inc 2830
CYTK Nasdaq Cytokinetics, Incorporated 2830
DERM Nasdaq Journey Medical Corporation 2830
DFTX Nasdaq Definium Therapeutics, Inc. 2830
DRMA Nasdaq Dermata Therapeutics, Inc. 2830
EIKN Nasdaq Eikon Therapeutics, Inc. 2830
ELAN New York Elanco Animal Health Incorporated 2830
ENLV Nasdaq Enlivex Ltd. 2830
EOCN Nasdaq Eocene Ltd. 2830
EOLS Nasdaq Evolus, Inc. 2830
EQ Nasdaq Equillium, Inc. 2830
ESAIY Over the counter Eisai Co., Ltd. 2830
ESLA Nasdaq Estrella Immunopharma, Inc. 2830
ETON Nasdaq Eton Pharmaceuticals, Inc. 2830
EVAX Nasdaq Evaxion A/S 2830
EVGN Nasdaq Evogene Ltd. 2830
EWTX Nasdaq Edgewise Therapeutics, Inc. 2830
EXEL Nasdaq Exelixis, Inc. 2830
FBIO Nasdaq Fortress Biotech, Inc. 2830
FENC Nasdaq Fennec Pharmaceuticals Inc. 2830
FHTX Nasdaq Foghorn Therapeutics Inc. 2830
FTRE Nasdaq Fortrea Holdings Inc. 2830
GILD Nasdaq Gilead Sciences, Inc. 2830
GKOS New York Glaukos Corporation 2830
GLUE Nasdaq Monte Rosa Therapeutics, Inc. 2830
GMAB Nasdaq Genmab A/S 2830
GNLX Nasdaq Genelux Corporation 2830
GOSS Nasdaq Gossamer Bio, Inc. 2830
GRCE Nasdaq Grace Therapeutics, Inc. 2830
GRI Nasdaq GRI Bio, Inc. 2830
GYRE Nasdaq Gyre Therapeutics, Inc. 2830
HLN New York Haleon plc 2830
Results 50 through 100 of 255